Al Amyloidosis
📧 Sign up to get email alerts when something new happens for Al Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation
This update reports long-term outcomes for patients with AL amyloidosis who underwent autologous stem cell transplantation. It includes surv…
-
CLINICAL_TRIALS trial_result · 2013-11-29Clinical Trial Update: Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis [Phase 3]
Phase 3 trial comparing bortezomib and dexamethasone followed by autologous stem cell transplant versus autologous stem cell transplant alon…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis [Phase 2]
Phase 2 trial evaluating lenalidomide with melphalan and dexamethasone in AL amyloidosis has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study evaluating Human Immune Globulin for AL amyloidosis-related heart dysfunction. Results w…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Radioimmunoimaging of Light Chain (AL) Amyloidosis [Phase 1]
The update reports completion of a Phase 1 trial evaluating a radioimmunoimaging approach for AL amyloidosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Radioimmunoimaging of AL Amyloidosis [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating a radioimmunoimaging approach for AL amyloidosis.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis [Phase 2]
A Phase 2 clinical trial evaluating the combination of melphalan, thalidomide, and dexamethasone in patients with newly diagnosed primary sy…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis [Phase 2]
A Phase 2 trial evaluating bortezomib, cyclophosphamide, and dexamethasone in patients with AL amyloidosis has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis [Phase 2]
A Phase 2 clinical trial evaluating 4'-Iodo-4'-Deoxydoxorubicin in patients with AL amyloidosis and related plasma cell neoplasms has comple…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Radioimmunoimaging of AL Amyloidosis [Phase 1]
Phase 1 clinical trial evaluating radioimmunoimaging for AL amyloidosis has completed, sponsored by the University of Tennessee.
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis [Phase 2]
Phase 2 clinical trial update of cyclophosphamide, lenalidomide, and dexamethasone (CLD) for previously treated AL amyloidosis. The trial ha…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis [Phase 2]
Phase 2 trial update reporting efficacy results for lenalidomide (Revlimid) in patients with AL amyloidosis (primary systemic amyloidosis).